Skip to Main Content

Author Details

Jeffrey N Myers
The University of Texas MD Anderson Cancer Center
1988
352
74
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36597662Spatial PD-L1, immune-cell microenvironment, and genomic copy-number alteration patterns and drivers of invasive-disease transition in prospective oral precancer cohort.Cancer2023
37604640<i>TP53</i> gain-of-function mutation modulates the immunosuppressive microenvironment in non-HPV-associated oral squamous cell carcinoma.J Immunother Cancer2023
37568707A Deep Learning Onion Peeling Approach to Measure Oral Epithelium Layer Number.Cancers (Basel)2023
37535378Outcomes of Treatment With Neoadjuvant Cemiplimab for Patients With Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck: Secondary Analysis of a Phase 2 Clinical Trial.JAMA Otolaryngol Head Neck Surg2023
37285560Beta-Blocker Use Is Associated With Worse Relapse-Free Survival in Patients With Head and Neck Cancer.JCO Precis Oncol2023
37012319Evolution of cisplatin resistance through coordinated metabolic reprogramming of the cellular reductive state.Br J Cancer2023
36721313Deep learning-based pathology image analysis predicts cancer progression risk in patients with oral leukoplakia.Cancer Med2023
36720835ASO Visual Abstract: Impact of Cancer Care Regionalization on Patient Volume.Ann Surg Oncol2023
36581726Impact of Cancer Care Regionalization on Patient Volume.Ann Surg Oncol2023
36689560Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma.Clin Cancer Res2023
36603172<i>HRAS</i> Mutations Define a Distinct Subgroup in Head and Neck Squamous Cell Carcinoma.JCO Precis Oncol2023
35301263A general calculus of fitness landscapes finds genes under selection in cancers.Genome Res2022
35443062Induction chemotherapy with or without erlotinib in patients with head and neck squamous cell carcinoma amenable for surgical resection.Clin Cancer Res2022
35834946Fusobacterium is enriched in oral cancer and promotes induction of programmed death-ligand 1 (PD-L1).Neoplasia2022
35426183Histopathologic features predictive of metastasis and survival in 230 patients with cutaneous squamous cell carcinoma of the head and neck and non-head and neck locations: a single-center retrospective study.J Eur Acad Dermatol Venereol2022
35419587Correction: Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck.Clin Cancer Res2022
36420184Evolutionary Action Score of <i>TP53</i> Analysis in Pathologically High-Risk Human Papillomavirus-Negative Head and Neck Cancer From a Phase 2 Clinical Trial: NRG Oncology Radiation Therapy Oncology Group 0234.Adv Radiat Oncol2022
35972731Combined TRIP13 and Aurora Kinase Inhibition Induces Apoptosis in Human Papillomavirus-Driven Cancers.Clin Cancer Res2022
35902768Mutant p53 drives an immune cold tumor immune microenvironment in oral squamous cell carcinoma.Commun Biol2022
35927986High enhancer activity is an epigenetic feature of HPV negative atypical head and neck squamous cell carcinoma.Front Cell Dev Biol2022
36053203Clinical Trial Development in TP53-Mutated Locally Advanced and Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma.J Natl Cancer Inst2022
36155359Outcomes for recurrent oral cavity squamous cell carcinoma.Oral Oncol2022
35238096Outcomes after definitive surgery for mandibular osteoradionecrosis.Head Neck2022
33146897The mutational landscape of early- and typical-onset oral tongue squamous cell carcinoma.Cancer2021
35665023Medication-Related Osteonecrosis of the Jaw in Patients Treated Concurrently with Antiresorptive and Antiangiogenic Agents: Systematic Review and Meta-Analysis.J Immunother Precis Oncol2021
33603199Retraction Note to: The Akt inhibitor KP372-1 suppresses Akt activity and cell proliferation and induces apoptosis in thyroid cancer cells.Br J Cancer2021
33522021Cytotoxic and targeted systemic therapy in patients with advanced cutaneous squamous cell carcinoma in the head and neck.Head Neck2021
33738875Characterizing distant metastases and survival in oropharyngeal squamous cell carcinoma.Head Neck2021
33873251Outcomes of patients with oropharyngeal squamous cell carcinoma treated with induction chemotherapy followed by concurrent chemoradiation compared with those treated with concurrent chemoradiation.Cancer2021
33788956The impact of induction and/or concurrent chemoradiotherapy on acute and late patient-reported symptoms in oropharyngeal cancer: Application of a mixed-model analysis of a prospective observational cohort registry.Cancer2021
33930368Mu-opioid receptor activation promotes in vitro and in vivo tumor growth in head and neck squamous cell carcinoma.Life Sci2021
33806894Epithelial Mutant p53 Promotes Resistance to Anti-PD-1-Mediated Oral Cancer Immunoprevention in Carcinogen-Induced Mouse Models.Cancers (Basel)2021
34732714Inhibition of histone acetyltransferase function radiosensitizes CREBBP/EP300 mutants via repression of homologous recombination, potentially targeting a gain of function.Nat Commun2021
34187851Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck.Clin Cancer Res2021
34021022Local Anti-PD-1 Delivery Prevents Progression of Premalignant Lesions in a 4NQO-Oral Carcinogenesis Mouse Model.Cancer Prev Res (Phila)2021
34038587Low doses of methylnaltrexone inhibits head and neck squamous cell carcinoma growth in vitro and in vivo by acting on the mu-opioid receptor.J Cell Physiol2021
34358340Elective neck dissection versus observation in patients with head and neck cutaneous squamous cell carcinoma.Cancer2021
34285940Proton Therapy for Head and Neck Cancer: A 12-Year, Single-Institution Experience.Int J Part Ther2021
34285931The Biological Basis for Enhanced Effects of Proton Radiation Therapy Relative to Photon Radiation Therapy for Head and Neck Squamous Cell Carcinoma.Int J Part Ther2021
33947685Combined Inhibition of Rad51 and Wee1 Enhances Cell Killing in HNSCC Through Induction of Apoptosis Associated With Excessive DNA Damage and Replication Stress.Mol Cancer Ther2021
32073931Targeting DNA damage response in head and neck cancers through abrogation of cell cycle checkpoints.Int J Radiat Biol2021
33277316Targeting of CD40 and PD-L1 Pathways Inhibits Progression of Oral Premalignant Lesions in a Carcinogen-induced Model of Oral Squamous Cell Carcinoma.Cancer Prev Res (Phila)2021
33334813Cancer-Associated Neurogenesis and Nerve-Cancer Cross-talk.Cancer Res2021
33190182Prevalence of medication related osteonecrosis of the jaw in patients treated with sequential antiresorptive drugs: systematic review and meta-analysis.Support Care Cancer2021
33352413Integrating depth of invasion in T classification improves the prognostic performance of the American Joint Committee on Cancer primary tumor staging system for cutaneous squamous cell carcinoma of the head and neck.Eur J Cancer2021
33320343Inclusion of extranodal extension in the lymph node classification of cutaneous squamous cell carcinoma of the head and neck.Cancer2021
31124563Disruption of TP63-miR-27a* Feedback Loop by Mutant TP53 in Head and Neck Cancer.J Natl Cancer Inst2020
33489162Reconstruction of intraoral oncologic surgical defects with Integra<sup>®</sup> bilayer wound matrix.Clin Case Rep2020
32051587Loss of p53 drives neuron reprogramming in head and neck cancer.Nature2020
31804658Association of Immunosuppression With Outcomes of Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck.JAMA Otolaryngol Head Neck Surg2020
  • 1 - 50 of 352

Recommended Authors

Stefano Cavalieri
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, University of Milan
Career Start Year 2016
Number of shared co-authors 2
Hua Li
University of California san francisco
Career Start Year 2013
Number of shared co-authors 8
Krupal B Patel
Moffitt Cancer Center
Career Start Year 2013
Number of shared co-authors 2
Neil Mundi
Southern Illinois University School of Medicine
Career Start Year 2013
Number of shared co-authors 1
Stefan Hartmann
University Hospital Wurzburg
Career Start Year 2013
Number of shared co-authors 2
Takahito Fukusumi
Osaka University Graduate School of Medicine
Career Start Year 2012
Number of shared co-authors 13
Alan L Ho
Memorial Sloan Kettering Cancer Center
Career Start Year 2009
Number of shared co-authors 12
Zhiyong Wang
Moores Cancer Center, University of California San Diego
Career Start Year 2008
Number of shared co-authors 14
Katharine A Price
Mayo Clinic
Career Start Year 2008
Number of shared co-authors 8
Farhoud Faraji
University of California San Diego Health
Career Start Year 2008
Number of shared co-authors 10
Julie E Bauman
George Washington University
Career Start Year 2007
Number of shared co-authors 21
Myung Woul Han
Ulsan University Hospital, University of Ulsan College of Medicine
Career Start Year 2006
Number of shared co-authors 1
Mizuo Ando
University of Tokyo
Career Start Year 2005
Number of shared co-authors 14
Sophia Bornstein
Cornell University
Career Start Year 2005
Number of shared co-authors 1
Nadeem Riaz
Memorial Sloan Kettering Cancer Center
Career Start Year 2004
Number of shared co-authors 8
Sabrina Daniela da Silva
Jewish General Hospital
Career Start Year 2004
Number of shared co-authors 2
Luc G T Morris
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 16
Wei Shi
Research Institute, Princess Margaret Cancer Centre
Career Start Year 2002
Number of shared co-authors 4
Akihiro Sakai
Tokai University
Career Start Year 2002
Number of shared co-authors 13
Robert I Haddad
Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 2001
Number of shared co-authors 19
Sana D Karam
University of Colorado School of Medicine
Career Start Year 2000
Number of shared co-authors 3
Eric J Sherman
Memorial Sloan Kettering Cancer Center
Career Start Year 1999
Number of shared co-authors 11
Rifat Hasina
University of Chicago Medicine
Career Start Year 1999
Number of shared co-authors 1
Yorihisa Imanishi
International University of Health and Welfare, Narita Hospital
Career Start Year 1996
Number of shared co-authors 0
Bhuvanesh Singh
Memorial Sloan Kettering Cancer Center
Career Start Year 1991
Number of shared co-authors 9
Charles R Leemans
Location Vrije Universiteit Amsterdam
Career Start Year 1990
Number of shared co-authors 7
Fei-Fei Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1988
Number of shared co-authors 7
Ravindra Uppaluri
Brigham and Women's Hospital
Career Start Year 1988
Number of shared co-authors 6
Ruud H Brakenhoff
Vrije Universiteit Amsterdam
Career Start Year 1986
Number of shared co-authors 7
Carter Van Waes
National Institute of Deafness and Other Communication Disorders
Career Start Year 1984
Number of shared co-authors 18

Collaborators

Adel K El-Naggar
MD Anderson Cancer Center
Co-authored papers 73
Mitchell J Frederick
Baylor College of Medicine
Co-authored papers 33
David I Rosenthal
MD Anderson Cancer Center
Co-authored papers 25
Stephen Y Lai
The University of Texas MD Anderson Cancer Center
Co-authored papers 16
Scott M Lippman
Moores Cancer Center, university of california san diego
Co-authored papers 15
Michelle D Williams
The University of Texas M. D. Anderson Cancer Center
Co-authored papers 12
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 9
Clifton D Fuller
The University of Texas MD Anderson Cancer Center
Co-authored papers 8
Beth M Beadle
Stanford University
Co-authored papers 8
Olivier Lichtarge
Baylor College of Medicine
Co-authored papers 7
Zhi-Yuan Zhang
Co-authored papers 6
David A Wheeler
Baylor College of Medicine
Co-authored papers 6
Jorge Silvio Gutkind
Moores Cancer Center, University of California San Diego
Co-authored papers 5
Andrew G Sikora
Co-authored papers 5
Jeffrey E Gershenwald
The University of Texas MD Anderson Cancer Center
Co-authored papers 5
Richard A Gibbs
Baylor College of Medicine
Co-authored papers 5
Theresa Guo
Moores Cancer Center, University of California
Co-authored papers 4
Min Gao
College of Horticulture, China Agricultural University
Co-authored papers 4
Michael A Davies
The University of Texas MD Anderson Cancer Center
Co-authored papers 4
Alexander Gelbard
Vanderbilt University Medical Center
Co-authored papers 4
Charles Lu
Co-authored papers 4
David B Weiner
Wistar Institute
Co-authored papers 4
Joseph A Califano
University of California
Co-authored papers 4
Chenping Zhang
Co-authored papers 4
Ryan Li
Oregon Health & Science University
Co-authored papers 3
Donna M Muzny
Baylor College of Medicine
Co-authored papers 3
Jennifer A Wargo
Co-authored papers 3
Timothy P Heffernan
Co-authored papers 3
Jennifer R Grandis
University of California san francisco
Co-authored papers 3
Woo Young Kim
Westchester Medical Center
Co-authored papers 3
Release 1.2